Chiesi Completes KalVista Acquisition, Expands Rare Disease Portfolio
Chiesi Group has completed its acquisition of KalVista Pharmaceuticals, marking a significant expansion of its rare…
Trending
- Chiesi Completes KalVista Acquisition, Expands Rare Disease Portfolio
- IMAAVY Shows Strong Results in Rare Blood Disorder Trial
- GSK’s Momelotinib Gains Orphan Status for VEXAS Syndrome
- FDA Grants Priority Review for Tecentriq in Colon Cancer
- China Approves Akeso’s Gumokimab for Plaque Psoriasis
- Parabilis Raises $845 Million Through IPO and Private Placement
- XtalPi Lands $400 Million AI Drug Discovery Partnership
- UK Approves First Oral Wegovy for Weight Management
- DePuy Synthes Launches AI-Powered Hip Navigation System
- Shaquille O’Neal Highlights Sleep Apnea Treatment With Zepbound
Top Headlines
IMAAVY Shows Strong Results in Rare Blood Disorder Trial
Johnson & Johnson has reported positive results from the Phase 2/3 ENERGY study evaluating IMAAVY®…
GSK’s Momelotinib Gains Orphan Status for VEXAS Syndrome
GSK has received a significant regulatory boost for its investigational efforts in rare diseases after both the…
FDA Grants Priority Review for Tecentriq in Colon Cancer
Roche has moved a step closer to expanding the use of its immunotherapy Tecentriq® (atezolizumab) in early-stage…
China Approves Akeso’s Gumokimab for Plaque Psoriasis
Akeso has secured regulatory approval in China for gumokimab (AK111), its internally developed anti-IL-17…
Parabilis Raises $845 Million Through IPO and Private Placement
Parabilis Medicines, Inc., a clinical-stage biopharmaceutical company focused on developing therapies against…
Featured Event
Clinical Trials
Massive Bio, Optellum Partner to Advance Lung Cancer Trial Access
Massive Bio and Optellum have announced a strategic collaboration designed to connect early lung cancer detection with faster access to clinical…
Phase 3 Success Boosts Prospects for Iza-Bren
SystImmune and Bristol Myers Squibb have reported positive Phase 3 results for izalontamab brengitecan (iza-bren), an investigational bispecific…
GSK Drug Bepirovirsen Shows Promise in Redefining Chronic Hepatitis B Treatment
British pharmaceutical company GSK has reported encouraging late-stage clinical trial results for bepirovirsen, an investigational therapy for chronic…
Regeneron Reports Promising Amyloidosis Trial Results
Regeneron Pharmaceuticals reported encouraging early-stage results from a Phase 1/2 clinical trial evaluating Lynozyfic (linvoseltamab) in patients…
Merck Phase 3 Trial Shows Promise in Endometrial Cancer
Global pharmaceutical company Merck & Co. has announced positive pivotal Phase 3 results for sacituzumab tirumotecan (sac-TMT), an investigational…
VOLGA Trial Shows Promise in Muscle-Invasive Bladder Cancer
AstraZeneca announced positive interim results from the Phase III VOLGA clinical trial, showing that perioperative treatment with Imfinzi combined…
Fast shipping, security and absolute privacy is our main goal Viagra-Buy.com/ savings on their medication from a licensed and certified pharmacy.
The best pharmacy in america Viagra-Buy.com Fast delivery, best prices and for real men
XtalPi Lands $400 Million AI Drug Discovery Partnership
XtalPi has entered into a strategic collaboration with a leading international biopharmaceutical company to develop…
Alnylam, Inceptive Forge $2 Billion AI Drug Discovery Deal
Alnylam Pharmaceuticals and Inceptive Nucleics have entered into a strategic collaboration valued at up to $2…
Drug Research
Latus Bio Raises $97 Million to Advance Gene Therapies
Latus Bio, Inc. has secured $97 million in Series A financing to accelerate the development of its gene therapy…
UK Streamlines Drug Approvals to Accelerate Patient Access
The Medicines and Healthcare products Regulatory Agency (MHRA) and National Institute for Health and Care…
Novartis Targets Breast Cancer With Novel PI3Kα Inhibitor Deal
Novartis has announced a strategic agreement with Synnovation Therapeutics, LLC to acquire SNV4818, an…
FDA Proposes New Steps to Streamline Biosimilar Drug Development
The U.S. Food and Drug Administration has announced a new regulatory initiative aimed at accelerating the…
Insilico, CMS Partner on AI Drug Discovery Programs
Clinical-stage biotechnology company Insilico Medicine and pharmaceutical commercialization group China Medical…
Manufacturing
Cellares, TScan Partner on Automated TSC-101 Manufacturing
Cellares and TScan Therapeutics have entered into a strategic agreement to evaluate automated clinical…
Fujifilm Expands Stem Cell Manufacturing in Wisconsin
FUJIFILM Cellular Dynamics has inaugurated a new headquarters and induced pluripotent stem cell (iPSC) development…
Piramal, Ajinomoto Partner to Advance ADC Manufacturing Capabilities
Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services have announced a strategic collaboration aimed at…
UCB Selects Georgia for Major U.S. Biologics Manufacturing Hub
UCB has announced plans to establish a major new biologics manufacturing facility in Gwinnett County, Georgia,…
LGM Pharma Expands U.S. Manufacturing With $15M Investment
LGM Pharma has announced a $9 million expansion across its U.S. manufacturing network, marking the second phase of…
Terumo BCT, Taiwan Bio Partner on Treg Manufacturing
Terumo Blood and Cell Technologies (Terumo BCT) has entered into a strategic collaboration with Taiwan Bio…
CordenPharma Leases New Lab Facility at Boulder’s Flatiron Park
BioMed Realty has announced that CordenPharma Colorado has signed a long-term lease for a new laboratory facility…
Novo Nordisk Invests €432M to Expand Irish GLP-1 Manufacturing
Pharmaceutical giant Novo Nordisk has announced a €432 million investment to expand its manufacturing facility in…
Diseases
Tenaya and Alnylam Partner to Discover New Genetic Targets for Heart Disease
Clinical-stage biotechnology company Tenaya Therapeutics has announced a new research collaboration with RNA…
AstraZeneca, CSPC Partner on Next-Generation Obesity Therapies
AstraZeneca has strengthened its weight management and metabolic disease pipeline through a new strategic…
China Approves ENHERTU for Second-Line HER2-Positive Gastric Cancer
China’s National Medical Products Administration (NMPA) has approved ENHERTU® (trastuzumab deruxtecan) for the…
InterAx, Alveus Partner to Advance Next-Generation Obesity Therapy
InterAx Biotech Ltd and Alveus Therapeutics Inc. have entered into a strategic research collaboration and licensing…
Sandoz to Acquire Just-Evotec Biologics Facility in Toulouse Under New Term Sheet
Sandoz has signed a non-binding term sheet with Evotec SE to potentially acquire Just–Evotec Biologics EU SAS,…
AstraZeneca and Revna Biosciences Expand Lung Cancer Treatment Access in Ghana
Since announcing their partnership in April 2025, AstraZeneca and Revna Biosciences have made significant strides…
